NeoImmuneTech, Inc.

NeoImmuneTech, Inc.

Share · KR8840140006 (XKOS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of NeoImmuneTech, Inc.
No Price
Closing Price XKOS 29.04.2026: 472,00 KRW
29.04.2026 06:30
Current Prices from NeoImmuneTech, Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XKOS: KOSDAQ
KOSDAQ
950220.KQ
KRW
29.04.2026 06:30
472,00 KRW
-3,00 KRW
-0,63 %
Company Profile for NeoImmuneTech, Inc. Share
NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases. The company was incorporated in 2014 and is headquartered in Rockville, Maryland.

Company Data

Name NeoImmuneTech, Inc.
Company NeoImmuneTech, Inc.
Website https://www.neoimmunetech.com
Primary Exchange XKOS KOSDAQ
ISIN KR8840140006
Asset Class Share
CEO Luke Yun Suk Oh
Market Capitalization 11 Mrd.
Country United States of America
Currency KRW
Employees 0,1 T
Address 2400 Research Blvd., 20850 Rockville
IPO Date 2021-03-16

Ticker Symbols

Name Symbol
KOSDAQ 950220.KQ
More Shares
Investors who hold NeoImmuneTech, Inc. also have the following shares in their portfolio:
BFCM 25/35 MTN
BFCM 25/35 MTN Bond
Coya Therapeutics, Inc. - Common Stock
Coya Therapeutics, Inc. - Common Stock Share